Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Piróg

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Disease Markers|December 13, 2019
Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal ContraceptionMagdalena Piróg, Sławomir Piwowarczyk, Anetta Undas
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 21, 2025
Age and BMI-related changes in hormonal profile in women with polycystic ovary syndrome (PCOS): Association with infertilityEwa Zabiegło, Robert Jach, Magdalena Piróg
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 3, 2017
Effects of ultra-low-dose versus standard hormone therapy on fibrinolysis and thrombin generation in postmenopausal womenMagdalena Piróg, Robert Jach, Anetta Undas
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 13, 2025
Tubal patency testing in women with polycystic ovary syndrome - is it worth before ovarian induction: Cost-effectiveness analysisMagdalena Piróg, Bartosz Chrostowski, Robert Jach
Acta Obstetricia Et Gynecologica Scandinavica|October 6, 2017
Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal womenMagdalena Piróg, Robert Jach, Olga Kacalska-Janssen
Archives of Gynecology and Obstetrics|April 27, 2026
Unfavorably altered fibrin clot properties in women with unexplained infertility: association with pregnancy outcomesMagdalena Piróg, Robert Jach, Michał Ząbczyk, et al.
Clinical Endocrinology|November 24, 2023
Nonclassical congenital adrenal hyperplasia: Metabolic and hormonal profileMagdalena Piróg, Anna Pulka, Ewa Zabiegło, et al.
Journal of Clinical Medicine|November 25, 2023
Increased Serum Levels of Phoenixin-14, Nesfatin-1 and Dopamine Are Associated with Positive Pregnancy Rate after Ovarian StimulationMagdalena Piróg, Robert Jach, Michał Ząbczyk, et al.
Archives of Gynecology and Obstetrics|October 17, 2025
Functional hypothalamic amenorrhea (FHA) in women with normal body mass index (BMI): metabolic and hormonal profilesDaryna Barouka, Olga Kacalska-Janssen, Robert Jach, et al.
Contemporary Oncology (Poznan, Poland)|May 8, 2019
The thin red line - postmenopausal abnormal uterine bleeding with endometrial thickness less than 4 mmMagdalena Piróg, Olga Kacalska-Janssen, Tomasz Bereza, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Disease Markers|December 13, 2019
Plasma Fibrin Clot Properties Are Unfavorably Altered in Women following Venous Thromboembolism Associated with Combined Hormonal ContraceptionMagdalena Piróg, Sławomir Piwowarczyk, Anetta Undas
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 21, 2025
Age and BMI-related changes in hormonal profile in women with polycystic ovary syndrome (PCOS): Association with infertilityEwa Zabiegło, Robert Jach, Magdalena Piróg
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 3, 2017
Effects of ultra-low-dose versus standard hormone therapy on fibrinolysis and thrombin generation in postmenopausal womenMagdalena Piróg, Robert Jach, Anetta Undas
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 13, 2025
Tubal patency testing in women with polycystic ovary syndrome - is it worth before ovarian induction: Cost-effectiveness analysisMagdalena Piróg, Bartosz Chrostowski, Robert Jach
Acta Obstetricia Et Gynecologica Scandinavica|October 6, 2017
Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal womenMagdalena Piróg, Robert Jach, Olga Kacalska-Janssen
Archives of Gynecology and Obstetrics|April 27, 2026
Unfavorably altered fibrin clot properties in women with unexplained infertility: association with pregnancy outcomesMagdalena Piróg, Robert Jach, Michał Ząbczyk, et al.
Clinical Endocrinology|November 24, 2023
Nonclassical congenital adrenal hyperplasia: Metabolic and hormonal profileMagdalena Piróg, Anna Pulka, Ewa Zabiegło, et al.
Journal of Clinical Medicine|November 25, 2023
Increased Serum Levels of Phoenixin-14, Nesfatin-1 and Dopamine Are Associated with Positive Pregnancy Rate after Ovarian StimulationMagdalena Piróg, Robert Jach, Michał Ząbczyk, et al.
Archives of Gynecology and Obstetrics|October 17, 2025
Functional hypothalamic amenorrhea (FHA) in women with normal body mass index (BMI): metabolic and hormonal profilesDaryna Barouka, Olga Kacalska-Janssen, Robert Jach, et al.
Contemporary Oncology (Poznan, Poland)|May 8, 2019
The thin red line - postmenopausal abnormal uterine bleeding with endometrial thickness less than 4 mmMagdalena Piróg, Olga Kacalska-Janssen, Tomasz Bereza, et al.
Pageof 3